These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19651082)

  • 1. Clinical significance of differences in area under the receiver operating characteristic curve: nomograms for predicting nonsentinel axillary lymph node metastasis.
    DiRusso SM
    J Am Coll Surg; 2009 Jul; 209(1):152; author reply 152. PubMed ID: 19651082
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
    Lambert LA; Ayers GD; Meric-Bernstam F
    Ann Surg Oncol; 2007 Aug; 14(8):2422-3. PubMed ID: 17514406
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
    Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
    Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer.
    Van Zee KJ; Kattan MW
    Ann Surg Oncol; 2007 Aug; 14(8):2177-8. PubMed ID: 17508249
    [No Abstract]   [Full Text] [Related]  

  • 11. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
    Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
    Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram.
    Degnim AC; Reynolds C; Pantvaidya G; Zakaria S; Hoskin T; Barnes S; Roberts MV; Lucas PC; Oh K; Koker M; Sabel MS; Newman LA
    Am J Surg; 2005 Oct; 190(4):543-50. PubMed ID: 16164917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
    Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
    Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience.
    Poirier E; Sideris L; Dubé P; Drolet P; Meterissian SH
    Ann Surg Oncol; 2008 Sep; 15(9):2562-7. PubMed ID: 18618183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'EreditĂ  G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients.
    Scow JS; Degnim AC; Hoskin TL; Reynolds C; Boughey JC
    Cancer; 2009 Sep; 115(18):4064-70. PubMed ID: 19517477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An axillary score (Barranger Score) to predict nonsentinel node metastasis in breast cancer patients with positive sentinel node.
    Coutant C; Uzan S; Morel O; Malartic C; Akerman G; Barranger E
    Am J Surg; 2008 Jan; 195(1):135-6. PubMed ID: 18070736
    [No Abstract]   [Full Text] [Related]  

  • 18. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
    Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
    Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study.
    Coutant C; Rouzier R; Fondrinier E; Marchal F; Guillemin F; Seince N; Rodrigues A; Darai E; Uzan S; Barranger E
    Breast Cancer Res Treat; 2009 Feb; 113(3):537-43. PubMed ID: 18340527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.
    Cho J; Han W; Lee JW; Ko E; Kang SY; Jung SY; Kim EK; Moon WK; Cho N; Park IA; Chung JK; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2008 Aug; 15(8):2278-86. PubMed ID: 18528729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.